Parkinson's disease (PD) is the second most common neurodegenerative disorder. The likelihood of developing PD increases with age. PD is rare before age 50. The average age of onset is in the mid to late 60s (Bower et al. 1999; de Rijk et al. 1995; Marras and Tanner 2002 ; Van den Eeden et al. 2003) . As the U.S. population ages, prevalence of this dis abling disorder is expected to rise dramatically (Dorsey et al. 2007) . Unfortunately, few valid data that address changes in PD incidence or prevalence over time are available. In fact, active casefinding efforts in communities detect as many as 10-40% of cases of PD for the first time, suggesting that underestima tion of PD prevalence is common (de Pedro Cuesta 1991; de Rijk et al. 1997) .
The symptoms of PD are slowly progres sive. Wellrecognized clinical features of PD are slowed movements, tremor, rigidity, and difficulties with gait and balance. However, other features commonly occur, including changes in olfaction, autonomic function, cognitive function, affect, sleep, and energy level (Alves et al. 2005; Burn et al. 2006; Pfeiffer 1998; Stern et al. 1994) .
In PD, specific neuronal populations degenerate. Neurodegeneration occurs in con cert with the deposition of aggregates of the protein alpha synuclein in neuronal cell bod ies and processes (Spillantini et al. 1998) . The classical focus has been on dopaminereleasing cells in the substantia nigra, because dopamine replacement can partially correct some of the motor features of PD. It has long been known, however, that many other neuronal popula tions are also affected in PD. Recently, converg ing epidemiologic and pathologic data suggest that years or even decades before the onset of these classical features of PD, neurons outside of the central nervous system may be injured (Abbott et al. 2005 (Abbott et al. , 2007 Braak et al. 2004; Langston 2006; Ross et al. 2008) . If this is cor rect, current concepts of PD will need revision. Clarification may provide exciting new oppor tunities for treatment and intervention.
In the 1980s, the observation that intra venous exposure to 1methyl4phenyl 1,2,3,6tetrahydropyridine (MPTP) caused parkinsonism in humans offered important insights into environmental triggers (Langston et al. 1983 (Tanner et al. 1999; Wirdefeldt et al. 2004) . Moreover, studies of uncommon genetic forms of PD have shown that changes in the structure of proteins that can lead to neural dysfunction, and death can also be caused independently by some environmental toxicants (Lee 2003; Purisai et al. 2005; Uversky et al. 2001; Vila et al. 2000) . As a result, a general view has evolved that the vast majority of cases of PD are caused by environmental factors interact ing with genetic makeup.
People with PD, their families, scientists, health care providers, and the general public are increasingly interested in identifying envi ronmental contributors to PD with an eye toward not only more effective treatments but also prevention. What percentage of cases involves preventable causes? What precau tionary interventions would be warranted and effective, and when must they be imple mented? Can individuals destined to develop neurologic dysfunction due to PD be identi fied before typical motor symptoms manifest?
The current scientific literature does not provide conclusive answers to most of these and other relevant questions. But indica tions from epidemiology, basic neurobiol ogy, and toxicology increasingly support the conclusion that a large portion of the risk of developing PD may be attributable to envi ronmental exposures. Therefore, the risk of PD is theoretically reducible to the extent that some cases may be preventable.
Purpose of Conference
Responding to these questions and concerns, a multidisciplinary group of experts gath ered in Sunnyvale, California, USA, 26-28 June 2007 , to assess what is known about the contribution of environmental factors to PD. Participants included toxicologists, epi demiologists, geneticists, neuroscientists, and medical practitioners. They were joined by representatives of PD advocacy groups and people with PD to review the state of envi ronmental health science as it pertains to PD.
The purposes of the meeting were as follows: • To review findings from diverse research disciplines concerning environmental factors that alone or in combination with genetic variables provide a biologic basis of PD • To identify conclusions that could be drawn with confidence from existing data • To identify plausible but uncertain conclu sions • To identify research gaps and needs and to describe features of a coherent research agenda. Participants recognized the existence of various syndromes that may share some clini cal and neurobiologic features with classic PD.
Sometimes the term "parkinsonism" is used to refer to these syndromes. They often involve more extensive (or less specific) brain injury than is typically seen in classic PD and can be degenerative or nondegenerative (e.g., car bon monoxide-induced parkinsonism, carbon tetrachloride-induced parkinsonism, vascular parkinsonism). However, boundaries between PD and parkinsonism are evolving concepts. For this reason, participants were not asked to discuss and come to a consensus definition of PD.
Participants did not attempt to rank spe cific pathogenic mechanisms with respect to their relative importance in PD causation. Nonetheless, various combinations of alpha synuclein deposition, mitochondrial dys function, proteosome dysfunction, oxidative stress, and inflammation arose in discussions of potential contributors in causal pathways.
Participants were also not asked to address and did not consider a) an exhaustive list of toxicants that have been associated with PD (examples of toxicants not considered include organic solvents, electromagnetic fields); or b) factors that may influence the progression of PD (as differentiated from causes of onset of PD).
Over the course of the meeting, the fol lowing core points of consensus were iden tified, which we offer in this summary to acquaint scientists, medical professionals, pub lic health advocates, and policy makers with the current state of understanding in the field, as seen by conference participants, and to help in identifying fruitful research strategies.
Findings

Sufficient evidence of a causal relationship.
Based on existing evidence, we are confident of the following:
• PD is a complex disorder, and multiple different pathogenic pathways and mecha nisms can ultimately lead to PD. Within the individual there are multiple determi nants of PD risk, and within populations the causes of PD are heterogeneous. The interplay among environmental factors and genetic makeup likely influences the risk of developing PD (Chade et al. 2006; Warner and Schapira 2003) .
• PD risk increases with age (Bower et al. 1999; de Rijk et al. 1995; Van den Eeden et al. 2003; Zhang et al. 2003 ).
• Studying PD is likely to increase understand ing of other neurodegenerative disorders.
• Rare recognized genetic mutations are suf ficient to cause PD (Singleton et al. 2003; Warner and Schapira 2003) . However, col lectively these genetic mutations account for < 10% of PD in the U.S. population. Moreover, even in these rare instances, incomplete penetrance suggests that environ mental factors may be involved (Elbaz 2008 ).
• In addition to rare genetic mutations, PD or parkinsonism can also rarely be induced primarily by exposure to toxicants that directly target the area of the brain involved in PD. MPTP is an example of such a toxi cant (Langston et al. 1983) . PD risk factors are categorized accord ing to the terminology of the Institute of Medicine (IOM) for strength of evidence. IOM committees sometimes classify the evi dence of association between exposure to a specific agent and a specific health outcome into five previously established categories, as set forth below. The group of experts gathered in Sunnyvale decided to use these catego ries as a means of describing their evaluation of the state of the evidence with respect to the influence of various factors on PD risk. Criteria for inclusion in each category are described at the outset.
Participants felt that these categories for describing the strength of evidence pertain ing to individual risk factors were useful even though not based here on a systematic evi dencebased literature review. Risk factors were assigned to the various categories based on consensus opinion of those attending the conference. Moreover, within each category there is no attempt to list the entries in any particular order.
Sufficient evidence of an association. In this IOM category, evidence from available studies is sufficient to conclude that there is a positive association. A consistent positive association has been observed between expo sure to a specific agent and a specific health outcome in human studies in which chance and bias, including confounding, could be ruled out with reasonable confidence. For example, several highquality studies report consistent positive associations, and the stud ies are sufficiently free of bias, including ade quate control for confounding.
• Men are at greater risk of PD than women (Bower et al. 1999; de Rijk et al. 1995; Van den Eeden et al. 2003) . However, increased risk to a disease can occur because of inher ently increased susceptibility, increased expo sures to causal agent(s), or combinations of the two . Current evi dence is not sufficient to explain with confi dence the increased risk in males.
• Evidence is sufficient to conclude with con fidence that cigarette smokers have a lower risk of PD than nonsmokers Ritz et al. 2007 ). PD risk may also be lower for people who use other tobacco products, although the evidence is not as extensive or persuasive as for cigarette smokers, and conference participants were less confident in drawing conclusions.
• Evidence is also sufficient to conclude that male coffee drinkers have a lower risk of PD than females (Ascherio et al. 2004; Ross et al. 2000) . For women coffee drinkers and people consuming other caffeinated bever ages, evidence is limited, but a similar pat tern seems to emerge (Ascherio et al. 2001) . Conference participants are confident of the associations but uncertain about the causal relationships or pathways by which smoking and coffee consumption might have a neuro protective effect. Various biologic mechanisms have been proposed. For example, nicotine in cigarettes and caffeine in coffee are hypoth esized to be agents that may confer a lower PD risk. However, noncausal explanations for these associations are also plausible , uncertainties remain, and no con sensus has been achieved. Nonetheless, further investigation into the biologic mechanisms by which female sex, cigarette smoking, and cof fee consumption lower PD risk is warranted and may result in important insights into the etiology and progression of PD.
Limited suggestive evidence of an association. In this IOM category, evidence from available studies suggests an association between exposure to a specific agent and a spe cific health outcome in human studies, but the body of evidence is limited by the inability to rule out chance and bias, including confound ing, with confidence. For example, at least one highquality study reports a positive asso ciation that is sufficiently free of bias, includ ing adequate control for confounding. Other corroborating studies provide support for the association, but they were not sufficiently free of bias, including confounding. Alternatively, several studies of less quality show consistent positive associations, and the results are prob ably not due to bias, including confounding.
Available scientific studies suggest an associ ation between a number of different factors and PD risk. Here, the data are limited but tend to point toward a valid association with PD risk. Causal mechanisms explaining the associations, if they exist, are not well understood.
• People with higher levels of physical activity have a reduced risk of PD (Thacker et al. 2008 ).
• Men, and possibly women, with higher blood urate levels have a reduced risk of PD (Davis et al. 1996; Weisskopf et al. 2007 ).
• People taking nonsteroidal antiinflamma tory drugs have a lower risk of PD (Powers et al. 2008a; Wahner et al. 2007 ).
• Men with high dietary intake of dairy prod ucts have an increased risk of PD Park et al. 2005 ).
• Farmers and agricultural workers have an increased risk of PD (Hertzman et al. 1994; Gorell et al. 1998; Tuchsen and Jensen 2000) . Epidemiologic studies often clas sify study participants according to their occupation and examine for associations between occupations and outcomes of inter est. In these cases, inferences about potential exposures that characterize those occupations may be drawn, but they remain as inferences and should not be confused with estimates of exposure to specific environmental agents. • People exposed to pesticides have an increased risk of PD (Dick et al. 2007; Gorell et al. 1998; Hancock et al. 2008; Kamel et al. 2007 ). However, epidemiologic study designs may classify study participants according to reported exposures to classes of chemicals or other agents. In these cases, associations between the class of environmental agents and outcome of interest may be identified, but in most cases specific agents that account for the association cannot be further identi fied from those data. Meeting participants note the evidence suggesting a direct associa tion between pesticide exposure and PD risk but are unable to draw any conclusions about specific agents that may be responsible.
• People with traumatic brain injury have an increased risk of PD (Bower et al. 2003 , Dick et al. 2007 Goldman et al. 2006 ).
• Certain variants of genes can modify the risk of PD. The risk may be higher or lower depending on the variant (Warner and Schapira 2003) . Inadequate/insufficient evidence to determine whether an association exists. In this IOM category, evidence from available studies is of insufficient quantity, quality, or consis tency to permit a conclusion regarding the existence of an association between exposure to a specific agent and a specific health out come in humans.
• People with higher dietary intake of poly unsaturated fatty acids have lower risk of PD (de Lau et al. 2005 ).
• People with higher blood cholesterol have lower risk of PD (Hu et al. 2008; Simon et al. 2007 ).
• Dietary sources of urate lower the risk of PD (Annanmaki et al. 2007; Gao et al. 2008 ).
• People taking statins are at lower risk of PD (Becker et al. 2008; Wahner et al. 2008 ).
• Postmenopausal women taking exogenous estrogen are at reduced risk of PD Popat et al. 2005 ).
• People with increased body mass index or body fat are at increased risk of PD (Hu et al. 2006; Logroscino et al. 2007 ).
• Women occupationally exposed to poly chlorinated biphenyls (electrical capacitance workers) are at increased risk of PD Steenland et al 2006) . • People with higher educational level are at higher risk of PD (Frigerio et al. 2005 ).
• People exposed to some specific pesticides have an increased risk of PD (paraquat, maneb, dieldrin) (Dick 2006; Drechsel and Patel 2008; Kamel et al. 2007) . In vitro and in vivo laboratory animal studies of some specific pesticides (e.g., rotenone, paraquat, maneb) demonstrate toxicity to nigral dopaminergic neurons and reveal biologic mechanisms by which exposure to those pesticides is plausibly linked to PD risk (Thiruchelvam et al. 2000; Uversky 2004 ). • People exposed to some heavy metals have an increased risk of PD (Gorell et al. 1998; Mergler et al. 1994) . Limited suggestive evidence of no association. In this IOM category, evidence from available studies is consistent in not showing a positive association between exposure to a specific agent and a specific health outcome after exposure of any magnitude. A conclu sion of no association is inevitably limited to the conditions, magnitudes of exposure, and length of observation in the available studies. The possibility of a very small increase in risk after exposure studied cannot be excluded.
Welding is not associated with risk of PD (Marsh and Gula 2006; Santamaria et al. 2007) .
Consensus not reached on category of association. In this IOM category, if the entire committee did not agree on a conclusion, then the association was not assigned a category.
• People living in rural areas have/do not have (Kuopio et al. 1999; Priyadarshi et al. 2001 ) an increased risk of PD.
• Vitamin E, vitamin C, and carotenoids are/ are not associated with PD risk (Etminan et al. 2005; Zhang et al. 2002 ).
• Dietary saturated fats are/are not associated with risk of PD (de Lau et al. 2005; Gao et al. 2007; Powers et al. 2008b ).
• Well water drinking is/is not associated with PD risk (Kuopio et al. 1999; Priyadarshi et al. 2001 ).
• Race/ethnicity is/is not associated with PD risk (Mayeux et al 1995; Van den Eeden et al. 2003; Zhang and Román 1993) .
Research Needs
• Welldesigned casecontrol studies with suf ficient power are needed-perhaps through consortia or multicenter-as well as strict attention to bias and confounding.
• Consider the question of appropriate con trol groups. Consider alternatives to tradi tional sources of controls used in the past such as random digit dialing and centers for Medicare and Medicaid services, as these sources are now often impractical because of privacy and other considerations.
• PD registries, particularly inclusive, legally mandated, populationbased registries, are essential to description of demographic, geo graphic, and temporal patterns and trends.
• Diagnostic criteria for cases need to be well defined in studies. Criteria and disease defi nition may vary depending on the specific hypothesis being tested. 
Research Questions
In addition to known risk factors for PD, conference participants identified a number of others in need of further investigation. Even for those that are well established, however, there is a need for additional information about mechanisms by which they influence PD risk. Moreover, in addition to individual risk factors, conference participants recog nized a need for further understanding of how risk factors interact as they contribute to the multiple pathogenic pathways that may ultimately result in PD.
